Brief: Palvella Therapeutics Appoints Rare Disease Commercial Veteran Ashley Kline As Chief Commercial Officer
27/05/2025 13:47
May 27 (Reuters) - Palvella Therapeutics Inc PVLA.O: PALVELLA THERAPEUTICS STRENGTHENS EXECUTIVE LEADERSHIP TEAM WITH APPOINTMENT OF RARE DISEASE COMMERCIAL VETERAN ASHLEY KLINE AS CHIEF COMMERCIAL OFFICER Source text: ID:nGNX8dRZS7 Further company coverage: PVLA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palvella Therapeutics
See all newsPalvella Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Palvella Therapeutics Q2 net loss widens on higher expenses
Brief: Palvella Therapeutics Announces New Data From The Phase 2 Toiva Trial Of Qtorin™ Rapamycin In Cutaneous Venous Malformations
Brief: Palvella Therapeutics Announces Uplisting To The Nasdaq Global Market
Palvella Therapeutics' Q1 net loss widens on higher costs